{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:48:07Z","timestamp":1787611687447,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-75-00004"],"award-info":[{"award-number":["20-75-00004"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The antimicrobial peptides human Beta-defensin-3 (hBD-3) and Epinecidin-1 (Epi-1; by Epinephelus coioides) could be a promising tool to develop novel antibacterials to combat antibiotic resistance. The antibacterial activity of Epi-1 + vancomycin against methicillin-resistant Staphylococcus aureus (22 isolates) and Epi-1 + hBD-3 against carbapenem-resistant isolates of Klebsiella pneumoniae (n = 23),\u00a0Klebsiella aerogenes (n = 17), Acinetobacter baumannii (n = 9), and Pseudomonas aeruginosa (n = 13) was studied in vitro. To evaluate the in vivo efficacy of hBD-3 and Epi-1, ICR (CD-1) mice were injected intraperitoneally with a lethal dose of K. pneumoniae or P. aeruginosa. The animals received a single injection of either sterile saline, hBD-3 monotherapy, meropenem monotherapy, hBD-3 + meropenem, or hBD-3 + Epi-1. Studied peptides showed antibacterial activity in vitro against all studied clinical isolates in a concentration of 2 to 32 mg\/L. In both experimental models of murine sepsis, an increase in survival rate was seen with hBD-3 monotherapy, hBD-3 + meropenem, and hBD-3 + Epi-1. For K.\u00a0pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.<\/jats:p>","DOI":"10.3390\/antibiotics11010076","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"76","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antimicrobial Peptides Epinecidin-1 and Beta-Defesin-3 Are Effective against a Broad Spectrum of Antibiotic-Resistant Bacterial Isolates and Increase Survival Rate in Experimental Sepsis"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2391-9135","authenticated-orcid":false,"given":"Albert","family":"Bolatchiev","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Stavropol State Medical University, 355000 Stavropol, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1473-3099(20)30456-4","article-title":"Global Increases in Antibiotic Consumption: A Concerning Trend for WHO Targets","volume":"21","author":"Roberts","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","unstructured":"O\u2019Neill, J. (2015). Review on Antimicrobial Resistance. Tackling a Global Health Crisis: Rapid Diagnostics: Stopping Unnecessary Use of Antibiotics. Indep. Rev. AMR, 1\u201336. Available online: https:\/\/amr-review.org\/."},{"key":"ref_3","unstructured":"US CDC (2019). Antibiotic Resistance Threats in the United States."},{"key":"ref_4","first-page":"48","article-title":"Antimicrobial Peptides: Mechanism of Action, Activity and Clinical Potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil. Med. Res."},{"key":"ref_5","first-page":"3919","article-title":"The Antimicrobial Peptides and Their Potential Clinical Applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106005","DOI":"10.1016\/j.ijantimicag.2020.106005","article-title":"Targeting Antimicrobial Drug Resistance with Marine Natural Products","volume":"56","author":"Barbosa","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial Peptides: An Emerging Category of Therapeutic Agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/ja8093247","article-title":"Broad-Spectrum Antimicrobial Peptides by Rational Combinatorial Design and High-Throughput Screening: The Importance of Interfacial Activity","volume":"131","author":"Rathinakumar","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e10455","DOI":"10.7717\/peerj.10455","article-title":"Antibacterial Activity of Human Defensins against Staphylococcus Aureus and Escherichia Coli","volume":"8","author":"Bolatchiev","year":"2020","journal-title":"PeerJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of Antimicrobial Peptides of the Innate Immune System in Combination with Conventional Antibiotics-a Novel Way to Combat Antibiotic Resistance?","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.aquaculture.2005.10.002","article-title":"Cloning, Expression and Antimicrobial Activity of an Antimicrobial Peptide, Epinecidin-1, from the Orange-Spotted Grouper, Epinephelus Coioides","volume":"253","author":"Yin","year":"2006","journal-title":"Aquaculture"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-019-0309-7","article-title":"Epinecidin-1, a Highly Potent Marine Antimicrobial Peptide with Anticancer and Immunomodulatory Activities","volume":"20","author":"Neshani","year":"2019","journal-title":"BMC Pharmacol. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3389\/fmicb.2019.02631","article-title":"Epinecidin-1, an Antimicrobial Peptide Derived From Grouper (Epinephelus Coioides): Pharmacological Activities and Applications","volume":"10","author":"Chee","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Huang, H.N., Pan, C.Y., Su, B.C., Wu, H.Y., and Chen, J.Y. (2019). Epinecidin-1 Protects against Methicillin Resistant Staphylococcus Aureus Infection and Sepsis in Pyemia Pigs. Mar. Drugs, 17.","DOI":"10.3390\/md17120693"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of Three Different in Vitro Methods of Detecting Synergy: Time-Kill, Checkerboard, and E Test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","article-title":"Synergy Tests by E Test and Checkerboard Methods of Antimicrobial Combinations against Brucella Melitensis","volume":"43","author":"Orhan","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02441-10","article-title":"Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Ep","volume":"49","author":"Pfaller","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.peptides.2013.04.004","article-title":"Truncated Antimicrobial Peptides from Marine Organisms Retain Anticancer Activity and Antibacterial Activity against Multidrug-Resistant Staphylococcus Aureus","volume":"44","author":"Lin","year":"2013","journal-title":"Peptides"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/archdischild-2015-309069","article-title":"What Do I Need to Know about Aminoglycoside Antibiotics?","volume":"102","author":"Germovsek","year":"2017","journal-title":"Arch. Dis. Child.-Educ. Pract."},{"key":"ref_21","unstructured":"Patel, S., Preuss, C.V., and Bernice, F. (2021, December 21). Vancomycin, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459263\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0732-8893(00)00175-9","article-title":"In-Vitro Activity and Killing Effect of Polycationic Peptides on Methicillin-Resistant Staphylococcus Aureus and Interactions with Clinically Used Antibiotics","volume":"38","author":"Giacometti","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1006\/bbrc.2001.6234","article-title":"Salt Resistance and Synergistic Effect with Vancomycin of \u03b1-Helical Antimicrobial Peptide P18","volume":"290","author":"Shin","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10096-014-2219-3","article-title":"Functional Synergy of \u03b1-Helical Antimicrobial Peptides and Traditional Antibiotics against Gram-Negative and Gram-Positive Bacteria in Vitro and in Vivo","volume":"34","author":"Feng","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/DDDT.S107195","article-title":"Synergistic Effects of Antimicrobial Peptide DP7 Combined with Antibiotics against Multidrug-Resistant Bacteria","volume":"11","author":"Wu","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/dna.2006.0564","article-title":"Gene Expression and Localization of the Epinecidin-1 Antimicrobial Peptide in the Grouper (Epinephelus Coioides), and Its Role in Protecting Fish Against Pathogenic Infection","volume":"26","author":"Pan","year":"2007","journal-title":"DNA Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rima, M., Rima, M., Fajloun, Z., Sabatier, J.M., Bechinger, B., and Naas, T. (2021). Antimicrobial Peptides: A Potent Alternative to Antibiotics. Antibiotics, 10.","DOI":"10.3390\/antibiotics10091095"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1128\/AAC.02958-14","article-title":"Epinecidin-1 Has Immunomodulatory Effects, Facilitating Its Therapeutic Use in a Mouse Model of Pseudomonas Aeruginosa Sepsis","volume":"58","author":"Pan","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.peptides.2012.04.002","article-title":"The Antimicrobial Peptide, Epinecidin-1, Mediates Secretion of Cytokines in the Immune Response to Bacterial Infection in Mice","volume":"36","author":"Lee","year":"2012","journal-title":"Peptides"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/psc.2978","article-title":"Synergistic Activity Profile of an Antimicrobial Peptide against Multidrug-Resistant and Extensively Drug-Resistant Strains of Gram-Negative Bacterial Pathogens","volume":"23","author":"Pollini","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/AAC.00904-10","article-title":"Structural Features Governing the Activity of Lactoferricin-Derived Peptides That Act in Synergy with Antibiotics against Pseudomonas Aeruginosa in Vitro and in Vivo","volume":"55","author":"Japelj","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0196-9781(00)00254-0","article-title":"Combination Studies between Polycationic Peptides and Clinically Used Antibiotics against Gram-Positive and Gram-Negative Bacteria","volume":"21","author":"Giacometti","year":"2000","journal-title":"Peptides"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bbamem.2006.07.007","article-title":"The Human Beta-Defensin-3, an Antibacterial Peptide with Multiple Biological Functions","volume":"1758","author":"Dhople","year":"2006","journal-title":"Biochim. Et Biophys. Acta (BBA)-Biomembr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1074\/jbc.M108830200","article-title":"The Solution Structures of the Human \u03b2-Defensins Lead to a Better Understanding of the Potent Bactericidal Activity of HBD3 against Staphylococcus Aureus","volume":"277","author":"Schibli","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly Accurate Protein Structure Prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_36","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2021, September 20). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 11.0. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2003). Determination of Minimum Inhibitory Concentrations (MICs) of Antibacterial Agents by Broth Dilution. Clin. Microbiol. Infect., 9, ix\u2013xv.","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.01106-08","article-title":"Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides","volume":"53","author":"Ruden","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.bbamem.2008.06.007","article-title":"Toroidal Pores Formed by Antimicrobial Peptides Show Significant Disorder","volume":"1778","author":"Sengupta","year":"2008","journal-title":"Biochim. Et Biophys. Acta-Biomembr."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Du Sert, N.P., Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., and Dirnagl, U. (2020). The ARRIVE Guidelines 2.0: Updated Guidelines for Reporting Animal Research. PLoS Biol., 18.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Van der Weide, H., ten Kate, M.T., Vermeulen-De Jongh, D.M.C., van der Meijden, A., Wijma, R.A., Boers, S.A., van Westreenen, M., Hays, J.P., Goessens, W.H.F., and Bakker-Woudenberg, I.A.J.M. (2020). Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella Pneumoniae Pneumonia\u2013Septicemia Model in Rats. Antibiotics, 9.","DOI":"10.3390\/antibiotics9030109"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/1\/76\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:38:21Z","timestamp":1760362701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/1\/76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["antibiotics11010076"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11010076","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,9]]}}}